AstraZeneca PLC (STO: AZN)
1,783.50
-4.00 (-0.22%)
Aug 30, 2024, 5:29 PM CET
AstraZeneca Revenue
AstraZeneca had revenue of $12.94B USD in the quarter ending June 30, 2024, with 13.33% growth. This brings the company's revenue in the last twelve months to $49.13B, up 10.45% year-over-year. In the year 2023, AstraZeneca had annual revenue of $45.81B with 3.29% growth.
Revenue (ttm)
$49.13B
Revenue Growth
+10.45%
P/S Ratio
5.31
Revenue / Employee
$546.53K
Employees
89,900
Market Cap
2,774.87B SEK
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 45.81B | 1.46B | 3.29% |
Dec 31, 2022 | 44.35B | 6.93B | 18.53% |
Dec 31, 2021 | 37.42B | 10.80B | 40.58% |
Dec 31, 2020 | 26.62B | 2.23B | 9.16% |
Dec 31, 2019 | 24.38B | 2.29B | 10.38% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Swedish Orphan Biovitrum AB (publ) | 23.71B |
Getinge AB (publ) | 33.33B |
Sectra AB (publ) | 3.04B |
Camurus AB (publ) | 1.59B |
Vitrolife AB (publ) | 3.54B |
Medicover AB (publ) | 21.70B |
Elekta AB (publ) | 18.12B |
Vimian Group AB (publ) | 3.91B |
AstraZeneca News
- 2 days ago - Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry - Benzinga
- 2 days ago - AstraZeneca share price has gone vertical; brace for a pullback - Invezz
- 3 days ago - Comparing Merck & Co With Industry Competitors In Pharmaceuticals Industry - Benzinga
- 3 days ago - We like to think UK health services aren’t influenced by big money. That’s just not true | Margaret McCartney - The Guardian
- 8 days ago - AstraZeneca Threatens To Move Vaccine Production Amid Reduced State Support - Benzinga
- 8 days ago - AstraZeneca refutes report of relocating U.K. vaccine production to U.S. - Seeking Alpha
- 8 days ago - AstraZeneca refutes report of relocating U.K. vaccine production to U.S. - Seeking Alpha
- 8 days ago - AstraZeneca warns of shifting UK vaccine production to US, FT reports - Zawya